Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5

Barbara Hopfgartner, Monika Kriz, Donat Alpar, Yvonne Westermaier, Marco H. Hofmann, Ralph A. Neumüller, Sarah Grosche

Open source

DOI
10.18632/oncotarget.28923
Published
2026-11-05
Container
Oncotarget
Publisher
Impact Journals, LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.28923,
  title = {Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5},
  author = {Barbara Hopfgartner and Monika Kriz and Donat Alpar and Yvonne Westermaier and Marco H. Hofmann and Ralph A. Neumüller and Sarah Grosche},
  year = {2026},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.28923},
  url = {https://doi.org/10.18632/oncotarget.28923}
}

RIS

TY  - JOUR
TI  - Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5
AU  - Barbara Hopfgartner
AU  - Monika Kriz
AU  - Donat Alpar
AU  - Yvonne Westermaier
AU  - Marco H. Hofmann
AU  - Ralph A. Neumüller
AU  - Sarah Grosche
PY  - 2026
JO  - Oncotarget
DO  - 10.18632/oncotarget.28923
UR  - https://doi.org/10.18632/oncotarget.28923
ER  - 

APA

Hopfgartner, B., Kriz, M., Alpar, D., Westermaier, Y., Hofmann, M. H., Neumüller, R. A., & Grosche, S. (2026). Limitation of the therapeutic potential of DUSP4 through adaptive feedback partially mediated by DUSP5. Oncotarget. https://doi.org/10.18632/oncotarget.28923

Source records